Skip to main content
. 2016 Sep 6;115(8):912–919. doi: 10.1038/bjc.2016.276

Figure 1.

Figure 1

Cumulative probability of non-persistence (continuous line) with 95 % confidence interval (dotted lines) estimated by the Cumulative Incidence Function method during the 5 years following hormonal therapy initiation using a 90-day gap as definition of non-persistence. The plateau observed at the end of the follow up is an artifact that is in relation to the 90-day gap retained to define non-persistence.